Bay Area Host Committee Names FleishmanHillard as Official Strategic Communications Consultancy for 2026

FH's Mitch Germann to Serve as Head of Communications; FleishmanHillard President & CEO J.J. Carter Joins BAHC Advisory Board The Bay Area Host Committee (BAHC) today announced a partnership with FleishmanHillard, naming the global communications firm as its Official Strategic Communications Consultancy for 2026. FleishmanHillard will serve as the communications division of BAHC, overseeing all […]

JHX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that James Hardie Industries plc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against James Hardie Industries plc. ("James Hardie" or "the Company") (NYSE:JHX) and certain of its officers. Class Definition This lawsuit seeks to recover

LNTH STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lantheus Holdings, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ:LNTH) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

New Crypto Mutuum Finance (MUTM) Nears $20M Raised as Phase 6 Hits 85% Allocation With V1 Ahead

New Crypto Mutuum Finance (MUTM) Nears $20M Raised as Phase 6 Hits 85% Allocation With V1 Ahead GlobeNewswire November 05, 2025 Dubai, UAE, Nov. 05, 2025 (GLOBE NEWSWIRE) — The crypto market continues to show growing interest in decentralized finance projects, and one name that keeps standing out is Mutuum Finance (MUTM). The project's presale

MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("MoonLake" or "the Company") (NASDAQ:MLTX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

KMX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that CarMax, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against CarMax, Inc. ("CarMax" or "the Company") (NYSE:KMX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Pomerantz LLP Issues Important Reminder to Investors in VF Corporation of Class Action Lawsuit – VFC

NEW YORK CITY, NY / ACCESS Newswire / November 5, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against VF Corporation ("VFC" or the "Company") (NYSE:VFC).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

Pluristyx Executes Key Commercial Clinical Use Licenses for iPSC Portfolio, Enabling Novel Therapies for Regenerative Medicine and Neurological Disease Therapeutics

SEATTLE, Nov. 05, 2025 (GLOBE NEWSWIRE) — Pluristyx, Inc., a leading biotechnology company specializing in tools and technologies for the development of induced pluripotent stem cell (iPSC)-based therapies, today announced the execution of two significant commercial clinical use licensing agreements. These agreements provide two innovative therapeutics companies with access to Pluristyx's clinical-grade iPSC lines and

QMCO Investors Have Opportunity to Lead Quantum Corporation Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESS Newswire / November 5, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Quantum Corporation ("Quantum" or "the Company") (NASDAQ:QMCO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

enBio Leads the Industry with a New Standard of Fairness and Transparency in Healthcare Technology Management (HTM)

New nationwide pricing model delivers clarity, fairness, and flexibility for hospital biomedical, HTM and Bed repair services. LOS ANGELES, CA / ACCESS Newswire / November 5, 2025 / As hospitals and clinics grapple with rising costs and unpredictable service pricing, enBio Corp is taking a principled stand – introducing a national model built on transparency,

Scroll to Top